y 27632 has been researched along with puromycin aminonucleoside in 1 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (puromycin aminonucleoside) | Trials (puromycin aminonucleoside) | Recent Studies (post-2010) (puromycin aminonucleoside) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 874 | 3 | 144 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellis, MJ; Fields, TA; Howell, DN; Spurney, RF; Wang, L | 1 |
1 other study(ies) available for y 27632 and puromycin aminonucleoside
| Article | Year |
|---|---|
Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis.
Topics: Amides; Animals; Antihypertensive Agents; Cells, Cultured; Disease Models, Animal; Epithelial Cells; Kidney Glomerulus; Membrane Proteins; Mice; Nephrosis; Podocytes; Puromycin Aminonucleoside; Pyridines; rho-Associated Kinases | 2008 |